Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Atkin

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
The Journal of Endocrinology|October 11, 2005
Notice of inadvertent duplicate publication: statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasoneC J Newton, G Ran, Y X Xie, et al.
British Journal of Cancer|December 4, 1998
Short-term primary culture of epithelial cells derived from human breast tumoursV Speirs, A R Green, D S Walton, et al.
Diabetes & Metabolism|May 23, 2018
Platelet function following induced hypoglycaemia in type 2 diabetesH Kahal, A Aburima, B Spurgeon, et al.
International Journal of Hygiene and Environmental Health|July 25, 2018
Perfluorinated alkyl acids in the serum and follicular fluid of UK women with and without polycystic ovarian syndrome undergoing fertility treatment and associations with hormonal and metabolic parametersA L Heffernan, T K Cunningham, D S Drage, et al.
Biochemical Pharmacology|December 15, 2019
Physiologically relevant screening of polyphenol-rich commercial preparations for bioactivity in vascular endothelial cells and application to healthy volunteers: A viable workflow and a cautionary taleH S Jones, M Papageorgiou, A Gordon, et al.
Clinical Endocrinology|January 3, 2013
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesityH Kahal, A Aburima, T Ungvari, et al.
Clinical Endocrinology|September 26, 2007
Home administration of lanreotide Autogel by patients with acromegaly, or their partners, is safe and effectiveJ S Bevan, J Newell-Price, J A H Wass, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor sizeJ S Bevan, S L Atkin, A B Atkinson, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
The Journal of Endocrinology|October 11, 2005
Notice of inadvertent duplicate publication: statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasoneC J Newton, G Ran, Y X Xie, et al.
British Journal of Cancer|December 4, 1998
Short-term primary culture of epithelial cells derived from human breast tumoursV Speirs, A R Green, D S Walton, et al.
Diabetes & Metabolism|May 23, 2018
Platelet function following induced hypoglycaemia in type 2 diabetesH Kahal, A Aburima, B Spurgeon, et al.
International Journal of Hygiene and Environmental Health|July 25, 2018
Perfluorinated alkyl acids in the serum and follicular fluid of UK women with and without polycystic ovarian syndrome undergoing fertility treatment and associations with hormonal and metabolic parametersA L Heffernan, T K Cunningham, D S Drage, et al.
Biochemical Pharmacology|December 15, 2019
Physiologically relevant screening of polyphenol-rich commercial preparations for bioactivity in vascular endothelial cells and application to healthy volunteers: A viable workflow and a cautionary taleH S Jones, M Papageorgiou, A Gordon, et al.
Clinical Endocrinology|January 3, 2013
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesityH Kahal, A Aburima, T Ungvari, et al.
Clinical Endocrinology|September 26, 2007
Home administration of lanreotide Autogel by patients with acromegaly, or their partners, is safe and effectiveJ S Bevan, J Newell-Price, J A H Wass, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor sizeJ S Bevan, S L Atkin, A B Atkinson, et al.
Pageof 13